AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2021
Feb 18, 2021
31676_dirs_2021-02-17_c4155cfc-c0e2-4e5b-b960-26eddca2a6e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2021-02-15
Reporting Person: Gutwerg Ori (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-15 | Common Stock | A | 12907 | — | Acquired | 12907 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-15 | Stock Option (right to buy) | $31.49 | A | 27006 | Acquired | 2031-02-15 | Common Stock (27006) | Direct |
Footnotes
F1: Represents a restricted stock award that will vest as to 25% of the total shares on each of February 15, 2022, February 15, 2023, February 15, 2024 and February 15, 2025.
F2: The option will vest and become exercisable as to 25% of the total shares on each of February 15, 2022, February 15, 2023, February 15, 2024 and February 15, 2025.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3